Candidatus Pannonibacter alzirae sp. nov. isolated from a septic immunocompromised patient in Brazil

Pannonibacter species. are non-fermentative Gram-stain-negative bacteria, with rare reports of human infections primarily affecting immunocompromised patients. Here, we report the genomic and phenotypic characterization of a novel Pannonibacter species, isolated from a bacteremia episode in a pediatric patient with acute lymphoblastic leukemia in Brazil. Initial characterization of the isolate (here named CBAS 1226) by MALDI-TOF mass spectrometry and 16S ribosomal RNA gene sequencing identified it as Pannonibacter sp., most closely related to P. phragmitetus. However, comparison of its MALDI-TOF spectrum with a commercial reference library revealed compatibility with only two of the five main spectra profiles for P. phragmitetus. This discrepancy motivated comprehensive genomic, biochemical, morphological, and antimicrobial resistance profiling of CBAS 1226. Genomic analysis revealed that Pannonibacter sp. CBAS 1226 is phylogenetically distinct from P. phragmitetus and other known species, with ANI and dDDH values below species delineation thresholds, supporting its proposal as Candidatus Pannonibacter alzirae. It forms small, non-hemolytic, grayish-white colonies on blood agar, similar to its closest relatives P. phragmitetus and P. indicus. Phenotypically, it is distinguished by positive α- and β-glucosidase activity, along with the utilization of citrate, L-proline, and 2-ketoglutarate. It is negative for alkaline phosphatase and unable to utilize D-fructose, D-melibiose, esculin, or L-arginine. The isolate exhibited higher MICs for β-lactams, whereas carbapenems and fluoroquinolones showed low MICs. The isolate is capable of forming biofilms and tolerates alkaline conditions, a wide range of temperatures, and different oxygen concentrations. Altogether, this report emphasizes the relevance of additional proteomics- and genomics-based approaches to clarify unusual bacterial infections and describes a new Pannonibacter species with distinct features and the potential to cause opportunistic infections.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.11.765890
Primary Topic
Infections and bacterial resistance
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Candidatus Pannonibacter alzirae sp. nov. isolated from a septic immunocompromised patient in Brazil

Gabriel Luz Wallau, João Luiz de Lemos Padilha Pitta, Maria J. R. Bezerra, Karina Lidianne Alcântara Saraiva et al.
bioRxiv (Cold Spring Harbor Laboratory)
Infections and bacterial resistance
preprint

Candidatus Pannonibacter alzirae sp. nov. isolated from a septic immunocompromised patient in Brazil

Gabriel Luz Wallau, João Luiz de Lemos Padilha Pitta, Maria J. R. Bezerra, Karina Lidianne Alcântara Saraiva, Matheus Filgueira Bezerra, Túlio de Lima Campos, Igor Vasconcelos Rocha, Carlos Alberto das Neves de Andrade, Beatriz Souza Toscano de Melo, Ana Carolina Mota de Faria, Reginaldo Gonçalves de Lima-Neto, Marise Sobreira, Marilia Lavocat Nunes
preprint en

Abstract

Pannonibacter species. are non-fermentative Gram-stain-negative bacteria, with rare reports of human infections primarily affecting immunocompromised patients. Here, we report the genomic and phenotypic characterization of a novel Pannonibacter species, isolated from a bacteremia episode in a pediatric patient with acute lymphoblastic leukemia in Brazil. Initial characterization of the isolate (here named CBAS 1226) by MALDI-TOF mass spectrometry and 16S ribosomal RNA gene sequencing identified it as Pannonibacter sp., most closely related to P. phragmitetus. However, comparison of its MALDI-TOF spectrum with a commercial reference library revealed compatibility with only two of the five main spectra profiles for P. phragmitetus. This discrepancy motivated comprehensive genomic, biochemical, morphological, and antimicrobial resistance profiling of CBAS 1226. Genomic analysis revealed that Pannonibacter sp. CBAS 1226 is phylogenetically distinct from P. phragmitetus and other known species, with ANI and dDDH values below species delineation thresholds, supporting its proposal as Candidatus Pannonibacter alzirae. It forms small, non-hemolytic, grayish-white colonies on blood agar, similar to its closest relatives P. phragmitetus and P. indicus. Phenotypically, it is distinguished by positive α- and β-glucosidase activity, along with the utilization of citrate, L-proline, and 2-ketoglutarate. It is negative for alkaline phosphatase and unable to utilize D-fructose, D-melibiose, esculin, or L-arginine. The isolate exhibited higher MICs for β-lactams, whereas carbapenems and fluoroquinolones showed low MICs. The isolate is capable of forming biofilms and tolerates alkaline conditions, a wide range of temperatures, and different oxygen concentrations. Altogether, this report emphasizes the relevance of additional proteomics- and genomics-based approaches to clarify unusual bacterial infections and describes a new Pannonibacter species with distinct features and the potential to cause opportunistic infections.

bioRxiv (Cold Spring Harbor Laboratory)
Universidade Federal de Pernambuco (BR), Ministério da Saúde (BR), Hospital das Clínicas da Universidade Federal de Pernambuco (BR), Instituto Aggeu Magalhães (BR)
Ministério da Saúde
Good health and well-being
Infections and bacterial resistance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon